A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy
Condition: Cardiomyopathy, Hypertrophic Obstructive Interventions: Drug: CT-20; Drug: Placebo Sponsor: Celltrion Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials